C
Cytokinetics
Cytokinetics | Muscle Biology Therapies | Home
At a glance
- Founded
- 1998
- Headquarters
- South San Francisco, United States
- Listing
- IPO 2004
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tier
Latest news
Press, funding announcements and product moves mentioning Cytokinetics.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later3 investors entered at this stage
- SFSevin Rosen Funds
- VGVale Group
- DUDuke University
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Patents
93 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Cytokinetics was the backer or acquirer, 2023–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Cytokinetics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Cytokinetics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cytokinetics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cytokinetics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.